Search research articles
Contact Us
Filters
Showing results (361-370 of 383) with videos related to
Page
of 39
Sort By:
AIDS Research and Human Retroviruses
|
May 17, 2012
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors
Wiriya Rutvisuttinunt, Sunee Sirivichayakul, Sineenart Oota, et al.
Journal of Invertebrate Pathology
|
September 25, 2023
Wild lime psyllid Leuronota fagarae Burckhardt (Hemiptera: Psylloidea) picorna-like virus full genome annotation and classification
Douglas S Stuehler, Wayne B Hunter, Yisel Carrillo-Tarazona, et al.
Physical Review Letters
|
December 30, 2017
Proton Spectra from ^{3}He+T and ^{3}He+^{3}He Fusion at Low Center-of-Mass Energy, with Potential Implications for Solar Fusion Cross Sections
A B Zylstra, J A Frenje, M Gatu Johnson, et al.
Pediatrics
|
September 11, 2013
Regional implementation of a pediatric cardiology chest pain guideline using SCAMPs methodology
Gerald H Angoff, David A Kane, Niels Giddins, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 4, 2020
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study
Clemente Diaz, Michael Koren, Leyi Lin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 3, 2007
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
Prasert Thongcharoen, Vinai Suriyanon, Robert M Paris, et al.
International Journal of Molecular Sciences
|
November 27, 2021
<i>CNGB3</i> Missense Variant Causes Recessive Achromatopsia in Original Braunvieh Cattle
Irene M Häfliger, Emma Marchionatti, Michele Stengård, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 29, 2020
Safety and Immunogenicity of an AS03<sub>B</sub>-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study
Leyi Lin, Kirsten E Lyke, Michael Koren, et al.
The Lancet. Infectious Diseases
|
June 2, 2012
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
Merlin L Robb, Supachai Rerks-Ngarm, Sorachai Nitayaphan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 25, 2012
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
Mark S de Souza, Silvia Ratto-Kim, Weerawan Chuenarom, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 383) with videos related to
Sort By:
Page
of 39
AIDS Research and Human Retroviruses
|
May 17, 2012
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors
Wiriya Rutvisuttinunt, Sunee Sirivichayakul, Sineenart Oota, et al.
Journal of Invertebrate Pathology
|
September 25, 2023
Wild lime psyllid Leuronota fagarae Burckhardt (Hemiptera: Psylloidea) picorna-like virus full genome annotation and classification
Douglas S Stuehler, Wayne B Hunter, Yisel Carrillo-Tarazona, et al.
Physical Review Letters
|
December 30, 2017
Proton Spectra from ^{3}He+T and ^{3}He+^{3}He Fusion at Low Center-of-Mass Energy, with Potential Implications for Solar Fusion Cross Sections
A B Zylstra, J A Frenje, M Gatu Johnson, et al.
Pediatrics
|
September 11, 2013
Regional implementation of a pediatric cardiology chest pain guideline using SCAMPs methodology
Gerald H Angoff, David A Kane, Niels Giddins, et al.
The American Journal of Tropical Medicine and Hygiene
|
March 4, 2020
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study
Clemente Diaz, Michael Koren, Leyi Lin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 3, 2007
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
Prasert Thongcharoen, Vinai Suriyanon, Robert M Paris, et al.
International Journal of Molecular Sciences
|
November 27, 2021
<i>CNGB3</i> Missense Variant Causes Recessive Achromatopsia in Original Braunvieh Cattle
Irene M Häfliger, Emma Marchionatti, Michele Stengård, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 29, 2020
Safety and Immunogenicity of an AS03<sub>B</sub>-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study
Leyi Lin, Kirsten E Lyke, Michael Koren, et al.
The Lancet. Infectious Diseases
|
June 2, 2012
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
Merlin L Robb, Supachai Rerks-Ngarm, Sorachai Nitayaphan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 25, 2012
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
Mark S de Souza, Silvia Ratto-Kim, Weerawan Chuenarom, et al.
Page
of 39